Vaxxas Pty Ltd

This early-stage study tested a new vaccine against H7N9 bird flu, given through a small skin patch instead of a needle. It involved 267 healthy adults aged 18 to 50. The main goal was to check if the vaccine is safe and tolerable, while also measuring the body's immune response.